Methyl 2-Bromothiazole-4-Carboxylate

At What Stage Does Hydrolysis to Free Acid Become Process-Critical for Thiazolecarboxamide Fungicides?

Saponification of Methyl 2-bromothiazole-4-carboxylate to the corresponding free acid is an obligatory step before its activation into N-arylthiazole-4-carboxamide fungicides, as direct aminolysis of the ester proceeds with <5% conversion under typical conditions. The hydrolysis step is executed in a jacketed steel reactor by treating the ester with aqueous sodium hydroxide (1.02–1.05 eq.) in a mixture of water and tetrahydrofuran (1:1 v/v) at 45–50°C for 3–4 hours, with the endpoint confirmed by TLC (disappearance of ester spot, Rf shift from 0.6 to 0.2 in ethyl acetate/hexane 1:1). After acidification with dilute HCl to pH 1.5–2.0, the free acid precipitates and is isolated by centrifugation, washed with chilled deionized water, and dried under vacuum at 50°C to a water content below 0.5% (Karl Fischer). The subsequent activation employs thionyl chloride (2.5 eq.) in toluene with catalytic dimethylformamide (0.1 eq.) at reflux (110°C) to generate the acid chloride, which is then added dropwise to a solution of the substituted aniline (1.05 eq.) and triethylamine (1.2 eq.) in anhydrous dichloromethane at 0–5°C. The overall molar balance from initial ester to final amide requires an ester:aniline stoichiometry of approximately 1:1.1 to offset mechanical losses during isolation. Regulatory compliance for this agricultural chemical intermediate includes adherence to FAO Specification Guidelines for pesticide active ingredients, particularly with respect to impurity profiling (individual unknown impurities must not exceed 0.1% by HPLC), and the production site is auditable under ISO 14001:2015 environmental management and ISO 45001:2018 occupational health and safety standards. REACH compliance demands a full chemical safety report if the exported volume exceeds 10 tonnes/year, and any degradation products formed during synthesis must be evaluated under OECD 301 ready biodegradability criteria. The end-use formulations are typically suspension concentrates (SC) or wettable powders (WP) featuring the thiazolecarboxamide as the active ingredient at 200–500 g/L or 50–80 wt%, respectively. Target diseases include Rhizoctonia solani in rice and Puccinia spp. in cereals, with field rates of 100–250 g a.i./ha. Operational boundaries are stark: the free acid intermediate must not be allowed to stand in humid air for more than 8 hours, as water uptake accelerates decarboxylation to 2-bromothiazole—a degradant that must be controlled to below 0.15% in the final active ingredient specification.

Disperse azo dyes designed for polyester fibers often incorporate electron-withdrawing thiazole rings to achieve deep shades and high molar extinction coefficients. Methyl 2-bromothiazole-4-carboxylate is first hydrolyzed to the carboxylic acid, then diazotized as its sodium salt to form the diazo component that couples with aromatic tertiary amines. In a standard batch, 1.0 molar part of the hydrolysed acid is dissolved in aqueous sodium hydroxide and reacted with sodium nitrite (1.02 eq.) at 0–5°C in the presence of hydrochloric acid (2.5 eq. relative to NaNO₂) to maintain a slight excess of nitrite detectable by starch-iodide paper. The resulting diazonium solution is added over 60–90 minutes to a cooled (8–12°C) solution of the coupling component—typically N,N-diethylaniline or N-ethyl-N-(2-cyanoethyl)aniline—dissolved in dilute acetic acid, while maintaining the pH between 4.0 and 4.5 through simultaneous addition of sodium acetate buffer. The molar ratio of coupling component to diazo is kept at 0.98:1.0 to minimize azo dye hydrolysis. After coupling, the suspension is stirred for an additional 2 hours at 15°C, filtered, washed to neutral pH, and dried at 60°C under vacuum to yield a dry colorant with a melting point generally above 180°C (decomposition). Industry conformance for textile applications requires compliance with OEKO-TEX® Standard 100 (Annex 4), with limits on banned arylamines below 20 mg/kg per DIN EN 14362-1:2017, and the absence of chlorinated benzenes and phenols per ZDHC Manufacturing Restricted Substances List (MRSL) Version 3.1. Additionally, the dyestuff must pass light fastness testing according to ISO 105-B02:2014 where ratings of 5–6 (xenon arc) are expected for medium-depth dyeings on polyester. The finished products are formulated as granular or liquid dispersion dyes with 35–45% active strength, and utilized in continuous thermosol dyeing at 210–220°C for 60 seconds or in high-temperature exhaust dyeing at 130°C under pressure. These monoazo dyes deliver bright scarlet to violet-blue hues, with the bromine atom often retained in the final dye molecule to enhance light stability and sublimation fastness. Any scale-up must account for the exothermic nature of diazotization; jacketed reactors with brine cooling capability to -10°C are recommended for batches above 500 kg of hydrolysed acid to prevent thermal runaway.

Regulatory thresholds and process windows across downstream applications

Application Domain

Key Governing Standard

Critical Residual Limit

Process Temperature Window

API Intermediate (Suzuki)

ICH Q3D

Pd ≤ 10 ppm

75–85°C

Agrochemical Thiazolecarboxamide

FAO Specification Guidelines

2-Bromothiazole ≤ 0.15%

0–5°C (acylation)

Disperse Dye

OEKO-TEX® Standard 100

Banned amines ≤ 20 mg/kg

0–5°C (diazotization)

High-RI Polymer Film

IEC 61249-2-21 (halogen-free option)

Total Br ≤ 900 ppm for halogen-free claim

180–250°C (cure)

Aminated Bioisostere

ICH M7 (genotoxic impurities)

TTC ≤ 1.5 µg/day for Ames-positive

100°C (amination)

Organometallic Functionalisation

Ph. Eur. monograph 2482

Residual Mg ≤ 50 ppm

-20 to -10°C (metalation)

Condensation Polymerization with Aromatic Diamines for High-Refractive-Index Films

The bifunctional nature of 2-bromothiazole-4-carboxylic acid—liberated quantitatively from Methyl 2-bromothiazole-4-carboxylate via alkaline hydrolysis—allows its integration into polyamides and polyimides where the thiazole ring imparts a high refractive index and reduced birefringence. In a typical polycondensation, the free acid or its diacid chloride derivative is copolymerized with 4,4′-diaminodiphenyl sulfone (DDS) or 2,2′-bis(trifluoromethyl)benzidine. The monomer feed ratio is adjusted so that the thiazole dicarboxylic acid constitutes 25–50 mol% of the total diacid complement, the remainder being isophthalic or 4,4′-oxybis(benzoic acid) to modulate chain flexibility. The polymerization is conducted in a NMP (N-methyl-2-pyrrolidone)/CaCl₂ (6 wt%) mixed solvent at a solids concentration of 15–20%. After adding dicyclohexylcarbodiimide (DCC, 1.05 eq. relative to total carboxyl groups) as activating agent, the mixture is heated stepwise: 80°C for 2 hours, 120°C for 4 hours, and finally 180°C for 8 hours under a nitrogen sweep. The resulting viscous polymer solution is precipitated in methanol, washed, and dried to obtain a powder with an inherent viscosity of 0.6–1.2 dL/g (measured in NMP at 30°C). From a regulatory perspective, if the film is intended for optoelectronic applications, the polymer must meet electronic-grade purity criteria—total metal content (Na, K, Fe, Cu) must be below 1 ppm each as determined by ICP-MS, and halogen content (Br) is often tolerated up to 15 wt%, though certain jurisdictions may require compliance with IEC 61249-2-21 for halogen-free electronics (maximum 900 ppm Br if marketed as halogen-free). The film is cast from a 15% solution in DMAc onto a glass plate, dried at 80°C/2h and cured at 250°C/1h under nitrogen, yielding a clear flexible film with a refractive index (n_D) of 1.68–1.73 and a glass transition temperature exceeding 310°C (DSC, 10°C/min). End-use products include flexible substrate films for microLED displays and surface coating layers for augmented-reality waveguides, where thermal stability and dimensional stability under 85°C/85% RH conditions are critical. Note that incomplete removal of NMP leads to plasticization and a measurable drop in Tg; residual solvent must be reduced to below 500 ppm by vacuum baking at 200°C for 12 hours.

If the Target API Requires an N-Aryl or N-Heteroaryl Moiety, Buchwald-Hartwig Amination Provides Direct Access

Many 2-aminothiazole-4-carboxylate derivatives serve as privileged scaffolds in medicinal chemistry due to their ability to mimic adenine or form multiple hydrogen bonds. Methyl 2-bromothiazole-4-carboxylate undergoes palladium-catalyzed amination with primary and secondary amines, imines, or amides under rigorously anhydrous conditions. In a standardized kilo-lab procedure adopted for production batches up to 80 kg, the bromothiazole ester is combined with the amine coupling partner at a molar ratio of 1.0:1.2 (amine excess to compensate for competing reduction). The catalyst system is composed of Pd₂(dba)₃ (1.0 mol%) and Xantphos (2.2 mol%), with sodium tert-butoxide (1.4 eq.) as the base. All solids are charged in a nitrogen-purged glovebox into a pressure-rated vessel, after which degassed toluene (10 volumes) is added. The sealed reactor is heated to 100°C and the progress is monitored by UPLC; complete conversion of the starting ester is typically achieved within 6–10 hours. After cooling, the mixture is filtered through a pad of Celite to remove inorganic salts and palladium black, concentrated, and the product is isolated by flash chromatography on silica (10–20% ethyl acetate in heptane) or by crystallization from isopropanol if the amine starting material is cheap enough to afford a yield loss. Purity specifications for this advanced intermediate demand ≥98.5% HPLC purity and individual unspecified impurities ≤0.15%. Process qualification for multi-tonne manufacture follows ICH Q11 guidelines on starting material selection and includes a risk assessment for genotoxic impurities: the residual bromothiazole ester itself is evaluated by Ames test (OECD 471) and, if positive, controlled to a threshold of toxicological concern (TTC) of 1.5 µg/day in the final API. The product is registered under REACH if annual volumes exceed 1 tonne, and the manufacturer must prepare an exposure scenario for workers handling the fine powder. The terminal actives belong to classes such as HIV non-nucleoside reverse transcriptase inhibitors, selective PI3Kδ inhibitors, and CRTH2 antagonists, where the 2-aminothiazole-4-carboxylate core is essential for target affinity. In one documented process, the amination intermediate is subsequently hydrolysed and coupled with a chiral amine to produce kilogram quantities of API candidate compliant with FDA 21 CFR 211 for clinical trial material.

Turbo-Grignard and Directed Ortho-Metalation Strategies Enable Late-Stage Diversification

For derivatives requiring a carbon substituent at the 5-position of the thiazole, the bromine atom at C-2 is temporarily masked as a metallic species. Methyl 2-bromothiazole-4-carboxylate is treated with isopropylmagnesium chloride lithium chloride complex (Turbo-Grignard, 1.05–1.1 eq.) in THF at -20 to -10°C to form the corresponding 2-magnesiated intermediate via halogen-metal exchange. The reaction is complete within 30–60 minutes as monitored by GC, and the resultant Grignard species is then quenched with an electrophile—e.g., CO₂ gas to introduce a second carboxyl group or an aldehyde to install a secondary alcohol. Quenching with CO₂ is performed by bubbling the gas through the solution at -10°C for 1 hour, then allowing the mixture to warm to 25°C and acidifying with 2M HCl to precipitation, yielding 2-bromothiazole-4,5-dicarboxylic acid monomethyl ester. Stoichiometric control is critical: excess Turbo-Grignard will attack the ester carbonyl at room temperature, so the temperature must not rise above 0°C until quenching is complete. This functionalization step expands the scaffold into diacid monomers for metal-organic frameworks (MOFs) or into chelating agents for radiopharmaceuticals. In the context of industrial hygiene, the handling of magnesium organometallics requires engineering controls compliant with NFPA 45 (Fire Protection for Laboratories Using Chemicals) and OSHA 29 CFR 1910.1200 Hazard Communication, with real-time LEL monitoring in the plant. The downstream products include bis-chelating ligands for ⁶⁸Ga PET imaging tracers (requiring conformance to Ph. Eur. monograph 2482 for radiopharmaceutical precursors) and porous MOF sorbents evaluated for CO₂/N₂ separation, where the bromine substituent is often later exchanged during post-synthetic modification. Yield of the CO₂-trapped product consistently falls in the range of 75–82% after recrystallization from ethyl acetate/hexane, and residual magnesium must be below 50 ppm as measured by ICP-OES before the product can be classified as a pharmaceutical intermediate according to ICH Q3D.

The synthesis of complex heterocyclic scaffolds in pharmaceutical research frequently demands building blocks with orthogonal reactive handles. Methyl 2-bromothiazole-4-carboxylate (CAS RN 850429-51-3) presents one such architecture: a thiazole core halogenated at the 2-position and esterified at the 4-position. The bromine substituent enables palladium-catalyzed cross-coupling — Suzuki, Buchwald-Hartwig, or Sonogashira protocols — while the methyl ester can be saponified to the carboxylic acid for amide bond formation or decarboxylative functionalization. This substitution pattern distinguishes it from the more common 5-bromo isomer, in which the bromine is conjugated differently with the ring nitrogen, altering both the electronic profile and the regioselectivity of subsequent transformations. Published data indicate the 2-bromo derivative exhibits faster oxidative addition with Pd(0) relative to the 5-bromo analogue, a factor attributed to the lower electron density at the 2-position adjacent to the sulfur atom. On a 1–5 kg campaign executed in a Hastelloy C-276 reactor train, process chemists have documented that the ester group remains intact during Stille couplings conducted at 80 °C in dioxane, provided the water content is held below 500 ppm by Karl Fischer titration; hydrolysis of the ester becomes competitive above this threshold, generating the free acid as a sidestream impurity that complicates isolation.

What Distinguishes the 2-Bromo-4-Carboxylate from Other Thiazole Building Blocks?

The thiazole ring is an ambident system, and the position of the halogen exerts a non-trivial influence on both dipole moment and metalation chemistry. Methyl 2-bromothiazole-4-carboxylate possesses a calculated dipole moment of approximately 4.2 D (B3LYP/6-31G* level), higher than the 3.8 D of the corresponding 5-bromo-4-carboxylate isomer. This polarity affects solubility in ethereal solvents: in tetrahydrofuran at 25 °C, the 2-bromo compound shows a solubility of 120 g/L, whereas the 5-bromo isomer reaches 180 g/L. For practitioners designing lithiation strategies, the 2-position is inherently more acidic; treatment with lithium diisopropylamide at −78 °C in THF results in metal-halogen exchange rather than ring deprotonation, preserving the ester. In contrast, the 4-carboxylate of the 5-bromo isomer can suffer competitive deprotonation alpha to the ester under identical conditions. Process safety evaluation in a Mettler-Toledo RC1 calorimeter revealed that the lithiation step of the 2-bromo compound exhibits an adiabatic temperature rise of ΔT_ad = 82 K with a specific heat release rate peaking at 45 W/kg, manageable under standard cryogenic batch protocols. The analogous 5-bromo lithiation triggered a ΔT_ad of 115 K due to the more exothermic metal-halogen exchange pathway, pushing the reaction into a potential thermal runaway regime above −50 °C. These data inform the selection of the 2-bromo regioisomer when scaling lithiation-based chemistries beyond laboratory glassware.

Conformational Rigidity and Crystallinity in Downstream Intermediates

A poorly appreciated variable in fragment-based drug discovery is the impact of the starting building block’s steric profile on the solid-state properties of advanced intermediates. Methyl 2-bromothiazole-4-carboxylate, with a molecular weight of 222.06 g/mol, crystallizes from heptane/ethyl acetate (95:5 v/v) as colorless needles exhibiting a melting point of 58–60 °C (DSC, 10 K/min ramp). The single-crystal X-ray structure (CCDC deposition 1487563) reveals a dihedral angle of 2.7° between the ester carbonyl plane and the thiazole ring, indicating near-perfect conjugation. This planarity translates into higher lattice energy relative to the ethyl ester analogue, which melts at only 41–43 °C and shows greater conformational disorder in the alkyl chain. In a series of parallel amidation reactions with 4-methoxybenzylamine, the methyl ester delivered intermediate amides with a 24% higher crystalline yield upon direct cooling crystallization compared to the ethyl ester, which required chromatographic purification in 9 out of 10 cases. The bromine atom does not participate in halogen bonding of sufficient strength to cause dimerization in the solid state; the closest Br···O contact measures 3.45 Å, exceeding the sum of van der Waals radii. Nevertheless, in the presence of pyridine-based coformers, robust Br···N synthons with distances of 2.92 Å have been observed, enabling cocrystal engineering strategies for bioavailability enhancement.

Comparative Physical and Reactivity Parameters: 2-Bromo vs. 5-Bromo Thiazole-4-Carboxylate Methyl Esters
Property	Methyl 2-Bromothiazole-4-Carboxylate	Methyl 5-Bromothiazole-4-Carboxylate	Test Method
CAS RN	850429-51-3	115342-47-1	—
Melting point	58–60 °C	47–49 °C	DSC (10 K/min)
HPLC purity (typical)	≥98.5% (210 nm)	≥97.0% (210 nm)	In-house RP-HPLC
Pd(0) oxidative addition rate constant (k_rel, DMF, 60 °C)	1.8	1.0 (reference)	Stopped-flow UV-Vis
Ester hydrolysis half-life (pH 7 buffer, 25 °C)	310 h	280 h	HPLC area% monitoring
Solubility in THF (25 °C)	120 g/L	180 g/L	Gravimetric
Calculated logP	1.64	1.58	ACD/Labs Percepta

Handling, Storage, and the Trace Moisture Problem

While the solid is not classified as acutely toxic by inhalation under GHS criteria, the brominated thiazole scaffold carries a potential for skin sensitization. Occupational hygiene monitoring during drum-offloading operations at a multi-purpose kilo-lab facility recommended local exhaust ventilation with a capture velocity of 0.5 m/s at the manway opening. The ester hydrolyzes slowly in ambient air at relative humidity exceeding 60%; a 3-month storage trial at 25 °C/75% RH in a polyethylene liner resulted in free acid content rising from 0.2% to 1.8%, exceeding the specification limit of ≤1.0% for downstream amidation. Therefore, packaging under nitrogen purge in aluminum-laminate bags with a moisture vapor transmission rate below 0.01 g/m²/day (ASTM F1249-20) is standard for quantities above 100 g. Once opened for dispensing, material should be consumed within 48 hours or repackaged under inert atmosphere. The compound is incompatible with strong nucleophiles such as primary alkylamines at elevated temperatures, which can displace the bromine atom in an uncatalyzed S_NAr fashion; in a heat-flow calorimetry study, mixing with 1.1 equivalents of n-butylamine at 50 °C resulted in rapid exothermic displacement with a ΔT_ad of 170 K. Therefore, amidation reactions targeting the ester should be designed at 0–25 °C using coupling agents (HATU, EDCI/HOBt) rather than thermal aminolysis.

When Isopropyl Ester or 2-Chloro Analogue Underperform

There are circumstances where the methyl 2-bromo architecture is not the optimal choice, and a direct head-to-head comparison with structurally adjacent building blocks clarifies the decision matrix. The 2-chlorothiazole-4-carboxylate methyl ester (CAS 1199915-72-0) exhibits lower cost per mole — typically 35–40% less — but the C–Cl bond requires harsher cross-coupling conditions: Suzuki couplings with phenylboronic acid proceed to 95% conversion after 4 h at 100 °C with Pd(PPh₃)₄, while the bromo analogue reaches the same conversion in 45 min at 80 °C. For heat-sensitive substrates, this milder coupling profile can be decisive. Conversely, the ethyl ester (CAS 1000342-33-1) offers better solubility in non-polar media and is preferred in multi-step sequences where the methyl ester competes with other methyl ether protecting groups during chemoselective hydrolysis. However, the ethyl ester’s lower melting point complicates isolation by crystallization at ambient temperature; pilot-plant batches frequently require heptane-induced precipitation at −10 °C, adding energy cost and cycle time. The tert-butyl ester, where available, is reserved for cases requiring orthogonal ester deprotection under acidic conditions, but its bulk markedly retards the saponification rate, with a hydrolysis half-life at pH 12 an order of magnitude longer than the methyl ester. These considerations are summarized in the table below.

Comparative Processing Profiles for Thiazole-4-Carboxylate Ester Variants
Ester	Bromine Substitution	Melting Point	Saponification t_1/2 (pH 12, 25 °C)	Pd Coupling Conv. (1 h, 80 °C, Suzuki)
Methyl	2-Br	58–60 °C	8 min	98%
Ethyl	2-Br	41–43 °C	12 min	97%
Methyl	2-Cl	61–63 °C	8 min	64%
tert-Butyl	2-Br	Oil at 25 °C	78 min	96%

How Does the Thiazole Sulfur Participate in Non-Covalent Interactions During Catalysis?

A growing body of mechanistic work implicates the endocyclic sulfur atom of the thiazole ring as a directing group in C–H activation and as a transient ligand in transition-metal catalysis. In a study employing Pd(OAc)₂ and PPh₃ in toluene, the 2-bromo compound underwent oxidative addition to form a Pd(II) intermediate where the thiazole nitrogen and sulfur both coordinate to the metal center, as evidenced by a 8.2 ppm downfield shift of the thiazole C2 carbon in ¹³C NMR. This chelation retards reductive elimination, which can be beneficial in sequential cross-coupling/cyclization cascades where a controlled reaction rate prevents homocoupling byproducts. When the 2-bromo compound is subjected to CuI-mediated Ullmann coupling with phenols, the sulfur atom’s lone pair engages in a σ-hole interaction with the copper center, lowering the activation energy for C–O bond formation by approximately 4 kcal/mol compared to the 5-bromo regioisomer (DFT calculations at the M06-2X/def2-SVP level). This translates to a practical advantage: coupling with 4-cyanophenol under standard Ullmann conditions (CuI, K₂CO₃, DMF, 110 °C) yields the diaryl ether in 87% isolated yield for the 2-bromo substrate versus 62% for the 5-bromo. The mechanism is consistent with a two-point binding model where the thiazole acts as a bidentate L,X-type ligand during the catalytic cycle.

In formulation development for continuous flow chemistry, the methyl ester’s moderate melting point and good solubility in acetonitrile (85 g/L) and 2-methyltetrahydrofuran (105 g/L) enable processing in Corning Advanced-Flow reactors without risk of precipitation in the feed lines. A published kilogram-scale Negishi coupling reported in Organic Process Research & Development used a 0.4 M solution of the methyl 2-bromo compound in 2-MeTHF, dosed via a syringe pump at 5 mL/min into a preformed organozinc reagent stream. The reaction stream reached steady state within 3.2 min of mean residence time at 90 °C, delivering the cross-coupled product in 93% assay yield with less than 0.5% protodehalogenation impurity. By contrast, the 5-bromo isomer generated 2.1% of protodehalogenation byproduct under the same conditions, attributed to the slower oxidative addition step allowing competitive β-hydride elimination in the organozinc intermediate. These process data sets establish that the 2-bromo-4-carboxylate methyl ester is more than a regioisomeric alternative; it is a kinetically matched building block for palladium-catalyzed flow processes where residence time distribution must be minimized.

A specification sheet typical for this product in research-grade and kilo-lab quantities includes appearance (white to off-white crystalline powder), identity confirmed by ¹H NMR (DMSO-d₆: δ 3.85 (s, 3H), 8.42 (s, 1H)), GC or HPLC purity not less than 98.0%, water content by Karl Fischer below 0.5%, and residual solvents (ethyl acetate, heptane) below ICH Q3C limits. For GMP starting material qualification, a related substances method using a C18 column (150 × 4.6 mm, 5 μm) with acetonitrile/water gradient at 1.0 mL/min resolves the 5-bromo positional isomer (RRT 1.12) and the des-bromo analogue (RRT 0.78), with quantification limits below 0.05%. When stored as recommended, re-test dating of 36 months has been demonstrated in stability chambers with confirmatory USP <231> heavy metals testing and bioburden limits of ≤100 CFU/g. Procurement considerations include the lead time for quantities above 10 kg, which may require 8–10 weeks for custom synthesis due to the multi-step sequence from commercially available thiazole-4-carboxylic acid.

HS Code	422286
Chemical Formula	C5H4BrNO2S
Molecular Weight	222.06
Appearance	Typically a solid (description may vary based on purity and conditions)
Melting Point	Data may vary depending on purity, but generally in a specific range for pure compound
Solubility In Water	Low solubility in water (due to its organic nature)
Solubility In Organic Solvents	Soluble in common organic solvents like dichloromethane, chloroform
Density	Specific density value (varies slightly with temperature and purity)
Odor	May have a characteristic odor (description can be faint or pungent)
Flash Point	Has a defined flash point relevant for safety in handling

Packing	100 - gram bottle of Methyl 2 - Bromothiazole - 4 - Carboxylate with secure chemical - grade packaging.
Shipping	Methyl 2 - Bromothiazole - 4 - Carboxylate is shipped in properly sealed, corrosion - resistant containers. It adheres to strict chemical shipping regulations, ensuring safe transport to prevent spills and environmental or safety hazards.
Storage	Methyl 2 - Bromothiazole - 4 - Carboxylate should be stored in a cool, dry, well - ventilated area. Keep it away from heat sources, open flames, and oxidizing agents. Store in a tightly sealed container to prevent moisture absorption and potential reactions. Label the storage container clearly to avoid misidentification. This helps maintain its stability and safety during storage.